Mitsubishi UFJ Securities’s Jazz Pharmaceuticals JAZZ Stock Holding History

Mitsubishi UFJ Securities’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-30	Closed	-$4K	–	42
2019 Q4	$4K	Hold	30	–	–	0.02%	79
2019 Q3	$4K	Hold	30	–	–	0.02%	84
2019 Q2	$4K	Hold	30	–	–	0.01%	204
2019 Q1	$4K	Hold	30	–	–	0.02%	130
2018 Q4	$4K	Hold	30	–	–	0.03%	96
2018 Q3	$5K	Hold	30	–	–	0.02%	195
2018 Q2	$5K	Hold	30	–	–	0.02%	191
2018 Q1	$5K	Hold	30	–	–	0.02%	198
2017 Q4	$4K	Hold	30	–	–	0.02%	206
2017 Q3	$4K	Hold	30	–	–	0.02%	189
2017 Q2	$5K	Hold	30	–	–	0.03%	185
2017 Q1	$4K	Hold	30	–	–	0.02%	200
2016 Q4	$3K	Hold	30	–	–	0.02%	219
2016 Q3	$4K	Hold	30	–	–	0.02%	201
2016 Q2	$4K	Hold	30	–	–	0.01%	223
2016 Q1	$4K	Hold	30	–	–	0.01%	192
2015 Q4	$4K	Hold	30	–	–	0.01%	251
2015 Q3	$4K	Hold	30	–	–	0.03%	229
2015 Q2	$5K	Hold	30	–	–	0.03%	229
2015 Q1	$5K	Buy	+30	New	+$5.15K	0.01%	240

Other funds holding JAZZ

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Mitsubishi UFJ Securities's JAZZ Position: Q1 2020 in Review

Mitsubishi UFJ Securities sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2020, closing a stake of 30 shares — an estimated $4K sold.

Mitsubishi UFJ Securities first reported a position in JAZZ in Q1 2015 and held it in 20 quarters. The position peaked at $5K in Q3 2018. 407 funds tracked by Wall St. Rank hold JAZZ as of Q1 2020.

Mitsubishi UFJ Securities reported no remaining Jazz Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Mitsubishi UFJ Securities sold 30 Jazz Pharmaceuticals shares in Q1 2020, an estimated $4K.
Mitsubishi UFJ Securities first reported a position in Jazz Pharmaceuticals in Q1 2015 and held it in 20 quarters.
Mitsubishi UFJ Securities's Jazz Pharmaceuticals position peaked at $5K in Q3 2018.
407 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2020.

Based on Mitsubishi UFJ Securities's 13F filing for Q1 2020, filed 13 May 2020.